Literature DB >> 31099941

Target Enzyme-Activated Two-Photon Fluorescent Probes: A Case Study of CYP3A4 Using a Two-Dimensional Design Strategy.

Jing Ning1, Wei Wang2, Guangbo Ge3, Peng Chu1,4, Feida Long4, Yongliang Yang4, Yulin Peng1, Lei Feng1,4, Xiaochi Ma1,5, Tony D James6.   

Abstract

The rapid development of fluorescent probes for monitoring target enzymes is still a great challenge owing to the lack of efficient ways to optimize a specific fluorophore. Herein, a practical two-dimensional strategy was designed for the development of an isoform-specific probe for CYP3A4, a key cytochrome P450 isoform responsible for the oxidation of most clinical drugs. In first dimension of the design strategy, a potential two-photon fluorescent substrate (NN) for CYP3A4 was effectively selected using ensemble-based virtual screening. In the second dimension, various substituent groups were introduced into NN to optimize the isoform-selectivity and reactivity. Finally, with ideal selectivity and sensitivity, NEN was successfully applied to the real-time detection of CYP3A4 in living cells and zebrafish. These findings suggested that our strategy is practical for developing an isoform-specific probe for a target enzyme.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  analytical methods; cytochrome P450 3A4; enzyme-activatable probes; fluorescent probes; molecular design

Year:  2019        PMID: 31099941     DOI: 10.1002/anie.201903683

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  10 in total

1.  A practical strategy to develop isoform-selective near-infrared fluorescent probes for human cytochrome P450 enzymes.

Authors:  Lei Feng; Xiangge Tian; Dahong Yao; Zhenlong Yu; Xiaokui Huo; Zhenhao Tian; Jing Ning; Jingnan Cui; Tony D James; Xiaochi Ma
Journal:  Acta Pharm Sin B       Date:  2021-11-25       Impact factor: 14.903

Review 2.  Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.

Authors:  Qiang Jin; JingJing Wu; Yue Wu; Hongxin Li; Moshe Finel; Dandan Wang; Guangbo Ge
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

3.  Evaluation of Fluorescent Cu2+ Probes: Instant Sensing, Cell Permeable Recognition and Quantitative Detection.

Authors:  Hao He; Zhao Cheng; Lei Zheng; Xuejiao Zhang
Journal:  Molecules       Date:  2021-01-19       Impact factor: 4.411

4.  The development of novel cytochrome P450 2J2 (CYP2J2) inhibitor and the underlying interaction between inhibitor and CYP2J2.

Authors:  Xiangge Tian; Meirong Zhou; Jing Ning; Xiaopeng Deng; Lei Feng; Huilian Huang; Dahong Yao; Xiaochi Ma
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 5.  Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications.

Authors:  Fang-Yuan Wang; Ping Wang; Dong-Fang Zhao; Frank J Gonzalez; Yu-Fan Fan; Yang-Liu Xia; Guang-Bo Ge; Ling Yang
Journal:  J Pharm Anal       Date:  2020-04-07

6.  A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis, and the development of inhibitor.

Authors:  Zhenhao Tian; Fei Yan; Xiangge Tian; Lei Feng; Jingnan Cui; Sa Deng; Baojing Zhang; Tian Xie; Shanshan Huang; Xiaochi Ma
Journal:  Acta Pharm Sin B       Date:  2021-06-08       Impact factor: 11.413

7.  Potent Inhibition of Human Cytochrome P450 3A4 by Biflavone Components from Ginkgo Biloba and Selaginella Tamariscina.

Authors:  Bo Wang; Chao Shi; Lei Feng; Wei Pan; Xiang-Ge Tian; Cheng-Peng Sun; Chao Wang; Jing Ning; Xia Lv; Yan Wang; Qian-Hui Yuan; Rui-Xuan Guan; Hou-Li Zhang; Xiao-Chi Ma; Tong-Hui Ma
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

8.  The Chinese herb Styrax triggers pharmacokinetic herb-drug interactions via inhibiting intestinal CYP3A.

Authors:  Feng Zhang; Tiantian Zhang; Jiahao Gong; Qinqin Fang; Shenglan Qi; Mengting Li; Yan Han; Wei Liu; Guangbo Ge
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

9.  Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.

Authors:  Jing Zhao; Saisai Tian; Dong Lu; Jian Yang; Huawu Zeng; Feng Zhang; Dongzhu Tu; Guangbo Ge; Yuejuan Zheng; Ting Shi; Xin Xu; Shiyi Zhao; Yili Yang; Weidong Zhang
Journal:  Phytomedicine       Date:  2020-09-09       Impact factor: 5.340

10.  A molecular-logic gate for COX-2 and NAT based on conformational and structural changes: visualizing the progression of liver disease.

Authors:  Yuehua Chen; Yuzhu Wang; Yonggang Yang; Yuhuan Li; Yafu Wang; Ge Wang; Tony D James; Xiaopeng Xuan; Hua Zhang; Yufang Liu
Journal:  Chem Sci       Date:  2020-05-25       Impact factor: 9.825

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.